FDA Approved Products

4,498 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
SEROQUEL XR
quetiapine
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
2007
NDA
30/100
SEROQUEL XR
quetiapine fumarate
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
2007
NDA
30/100
SERPALAN
reserpine
LOE Approaching
ORAL · TABLET
1955
NDA
30/100
SERPASIL
reserpine
LOE Approaching
Novartis
INJECTION · INJECTABLE
1954
NDA
30/100
SERPASIL
reserpine
LOE Approaching
Novartis
ORAL · ELIXIR
1955
NDA
30/100
SERPASIL-APRESOLINE
hydralazine hydrochloride; reserpine
LOE Approaching
Novartis
ORAL · TABLET
1954
NDA
30/100
SERPASIL-ESIDRIX #1
hydrochlorothiazide; reserpine
LOE Approaching
Novartis
ORAL · TABLET
1959
NDA
30/100
SERPASIL-ESIDRIX #2
hydrochlorothiazide; reserpine
LOE Approaching
Novartis
ORAL · TABLET
1959
NDA
30/100
SERZONE
nefazodone hydrochloride
LOE Approaching
Bristol Myers Squibb
ORAL · TABLET
1994
NDA
30/100
SETHOTOPE
selenomethionine se-75
LOE Approaching
Bracco
INJECTION · INJECTABLE
1973
NDA
30/100
SHADE UVAGUARD
avobenzone; octinoxate; oxybenzone
LOE Approaching
Bayer
TOPICAL · LOTION
1992
NDA
30/100
SILDAFLO
silver sulfadiazine
LOE Approaching
Inpharmus
TOPICAL · DRESSING
1989
NDA
30/100
SILVADENE
silver sulfadiazine
LOE Approaching
Pfizer
TOPICAL · CREAM
1973
NDA
30/100
SIMVASTATIN
simvastatin
LOE Approaching
ORAL · TABLET, ORALLY DISINTEGRATING
2007
SMNDA
30/100
SINE-AID IB
ibuprofen; pseudoephedrine hydrochloride
LOE Approaching
ORAL · TABLET
1992
NDA
30/100
SINEMET
carbidopa and levodopa
LOE Approaching
Merck & Co.
ORAL · TABLET
1975
NDA
30/100
SINEMET CR
carbidopa; levodopa
LOE Approaching
Merck & Co.
ORAL · TABLET, EXTENDED RELEASE
1991
NDA
30/100
SINEQUAN
doxepin hydrochloride
LOE Approaching
Pfizer
ORAL · CONCENTRATE
1974
NDA
30/100
SINEQUAN
doxepin hydrochloride
LOE Approaching
Pfizer
ORAL · CAPSULE
1969
NDA
30/100
SINGULAIR
montelukast sodium
LOE Approaching
Merck & Co.
ORAL · TABLET
1998
NDA
30/100
SINGULAIR
montelukast sodium
LOE Approaching
Merck & Co.
ORAL · TABLET, CHEWABLE
1998
NDA
30/100
SINGULAIR
montelukast sodium
LOE Approaching
Merck & Co.
ORAL · GRANULE
2002
NDA
30/100
SINOGRAFIN
diatrizoate meglumine; iodipamide meglumine
LOE Approaching
Bracco
INTRAUTERINE · SOLUTION
1958
NDA
30/100
SKELID
tiludronate disodium
LOE Approaching
Sanofi
ORAL · TABLET
1997
NDA
30/100
← PreviousPage 143 of 188Next →